menu
    • menu

    Company profile for Gossamer Bio

    NEW Drugs in Dev: 6
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of e...
    Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with a strong track record of execution in immunology, inflammation, fibrosis and oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Gossamer BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3013 Science Park Road, Suite 200 San Diego, CA 92121
    Telephone
    Telephone
    858-684-1300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gossamerbio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/gossamer-bio
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gossamer Announces Early Results of Convertible Notes Exchange
    Gossamer Announces Early Results of Convertible Notes Exchange

    03 Jun 2026

    // FIRSTWORD PHARMA

    https://www.businesswire.com/news/home/20260603588950/en/Gossamer-Bio-Inc.-Announces-Early-Tender-Results-and-Early-Settlement-for-Exchange-Offer-and-Consent-Solicitation-with-Respect-to-Existing-Convertible-Notes

    FIRSTWORD PHARMA
    03 Jun 2026
    Share Share
    Gossamer Extends Tender Date for Convertible Notes Exchange Offer
    Gossamer Extends Tender Date for Convertible Notes Exchange Offer

    02 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260602179111/en/Gossamer-Bio-Inc.-Announces-Extension-of-Early-Tender-Date-for-Exchange-Offer-and-Consent-Solicitation-with-Respect-to-Existing-Convertible-Notes

    BUSINESSWIRE
    02 Jun 2026
    Share Share
    Gossamer Bio Launches Exchange Offer to Eliminate $120M+ in Debt
    Gossamer Bio Launches Exchange Offer to Eliminate $120M+ in Debt

    18 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-18/gossamer-bio-inc-launches-exchange-offer-and-consent-solicitation-intended-to-eliminate-over-120

    PHARMIWEB
    18 May 2026
    Share Share
    Gossamer Bio Reports Q1 2026 Financial Results and Update
    Gossamer Bio Reports Q1 2026 Financial Results and Update

    18 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-18/gossamer-bio-announces-first-quarter-2026-financial-results-and-provides-business-update

    PHARMIWEB
    18 May 2026
    Share Share
    Gossamer Bio to Report Q1 2026 Results and Host Webcast on May 18
    Gossamer Bio to Report Q1 2026 Results and Host Webcast on May 18

    15 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260515184829/en/Gossamer-Bio-to-Announce-First-Quarter-2026-Financial-Results-and-Host-Conference-Call-and-Webcast-on-May-18-2026

    BUSINESSWIRE
    15 May 2026
    Share Share
    Gossamer, Biomx Reveal Hefty Staff Cuts
    Gossamer, Biomx Reveal Hefty Staff Cuts

    21 Mar 2026

    // BIOSPACE

    https://www.biospace.com/biospace-layoff-tracker

    BIOSPACE
    21 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search